![These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=emflaza-20.jpg&id=590113)
These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial
![Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes | Journal of Comparative Effectiveness Research Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/cms/10.2217/cer-2021-0110/asset/images/medium/figure4.gif)
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes | Journal of Comparative Effectiveness Research
![Update on pharmacology, actions, dosimetry and regimens of oral glucocorticoids in dermatology - Sardana - Journal of Cosmetic Dermatology - Wiley Online Library Update on pharmacology, actions, dosimetry and regimens of oral glucocorticoids in dermatology - Sardana - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4ad3f5e0-5563-4346-b338-6496704d8d70/jocd15108-fig-0007-m.jpg)
Update on pharmacology, actions, dosimetry and regimens of oral glucocorticoids in dermatology - Sardana - Journal of Cosmetic Dermatology - Wiley Online Library
![These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=emflaza-22.jpg&id=590113)
These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial
![Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials - McDonald - 2020 - Muscle & Nerve - Wiley Online Library Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials - McDonald - 2020 - Muscle & Nerve - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fed1f663-bd87-492c-8a20-4e09a27b561c/mus26736-fig-0001-m.jpg)
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials - McDonald - 2020 - Muscle & Nerve - Wiley Online Library
![These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=emflaza-23.jpg&id=590113)
These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial
![Download PDF | Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids Download PDF | Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids](https://i1.rgstatic.net/publication/312263309_Deflazacort_Therapeutic_index_relative_potency_and_equivalent_doses_versus_other_corticosteroids/links/5fc473faa6fdcc6cc6842ec5/largepreview.png)
Download PDF | Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids
![Determination of the correlation between the structure and dynamics of deflazacort by solid state NMR measurements - New Journal of Chemistry (RSC Publishing) DOI:10.1039/D0NJ03418E Determination of the correlation between the structure and dynamics of deflazacort by solid state NMR measurements - New Journal of Chemistry (RSC Publishing) DOI:10.1039/D0NJ03418E](https://pubs.rsc.org/image/article/2020/NJ/d0nj03418e/d0nj03418e-f3_hi-res.gif)
Determination of the correlation between the structure and dynamics of deflazacort by solid state NMR measurements - New Journal of Chemistry (RSC Publishing) DOI:10.1039/D0NJ03418E
![Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome | Iranian Journal of Pediatrics | Full Text Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome | Iranian Journal of Pediatrics | Full Text](http://services.brieflands.com/cdn/serve/33/bb/33bbf81095a2bed12527947e0ef8ab0290f7df13/ijp-25-2-510-i001-preview.png)
Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome | Iranian Journal of Pediatrics | Full Text
![Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry | BMC Neurology | Full Text Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-019-1304-8/MediaObjects/12883_2019_1304_Fig5_HTML.png)
Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry | BMC Neurology | Full Text
![Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy - ScienceDirect Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002944017305291-gr1.jpg)
Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy - ScienceDirect
![Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center | Journal of Comparative Effectiveness Research Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/cms/10.2217/cer-2019-0170/asset/images/medium/figure2.gif)